Literature DB >> 19633444

Recent trends in hypertension treatment: perspectives from animal studies.

Fedor Simko, Olga Pechanova.   

Abstract

Several newer areas of hypertension research are presented in this supplement. First, the benefits of melatonin in the treatment of experimental hypertension including its cardioprotective effects are introduced. Second, the possible role of melatonin in the non-dipping blood pressure pattern is described. Third, two hypotheses discuss the potential reasons for the ineffectivness of antioxidants in hypertension treatment, and difficulties associated with interpretations of experimental findings in the model of the spontaneously hypertensive rat (SHR). Finally, interactions of indapamide with the nitric oxide system in SHR, the protective effect of angiotensin II type 1 receptor blockade against alterations in insulin-resistant rats, and the deleterious effect of a low protein diet on kidney maturation with the development of hypertension are presented.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19633444     DOI: 10.1097/01.hjh.0000358829.87815.d4

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  5 in total

Review 1.  Peripheral and central effects of melatonin on blood pressure regulation.

Authors:  Olga Pechanova; Ludovit Paulis; Fedor Simko
Journal:  Int J Mol Sci       Date:  2014-10-08       Impact factor: 5.923

2.  Lactacystin-Induced Model of Hypertension in Rats: Effects of Melatonin and Captopril.

Authors:  Fedor Simko; Olga Pechanova; Kristina Repova; Silvia Aziriova; Kristina Krajcirovicova; Peter Celec; Lubomira Tothova; Stanislava Vrankova; Lucia Balazova; Stefan Zorad; Michaela Adamcova
Journal:  Int J Mol Sci       Date:  2017-07-25       Impact factor: 5.923

3.  Ivabradine and Blood Pressure Reduction: Underlying Pleiotropic Mechanisms and Clinical Implications.

Authors:  Fedor Simko; Tomas Baka
Journal:  Front Cardiovasc Med       Date:  2021-02-10

Review 4.  Evidence for the Benefits of Melatonin in Cardiovascular Disease.

Authors:  Mohammad Tobeiha; Ameneh Jafari; Sara Fadaei; Seyed Mohammad Ali Mirazimi; Fatemeh Dashti; Atefeh Amiri; Haroon Khan; Zatollah Asemi; Russel J Reiter; Michael R Hamblin; Hamed Mirzaei
Journal:  Front Cardiovasc Med       Date:  2022-06-20

5.  Effect of Melatonin on the Renin-Angiotensin-Aldosterone System in l-NAME-Induced Hypertension.

Authors:  Fedor Simko; Tomas Baka; Kristina Krajcirovicova; Kristina Repova; Silvia Aziriova; Stefan Zorad; Marko Poglitsch; Michaela Adamcova; Russel J Reiter; Ludovit Paulis
Journal:  Molecules       Date:  2018-01-29       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.